Eldecalcitol reduces the risk of severe vertebral fractures and improves the health-related quality of life in patients with osteoporosis.

Item

http://www.wikidata.org/entity/Q36662819

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Eldecalcitol reduces the risk ...... in patients with osteoporosis.

@ast

Eldecalcitol reduces the risk ...... in patients with osteoporosis.

@en

type

Item

label

Eldecalcitol reduces the risk ...... in patients with osteoporosis.

@ast

Eldecalcitol reduces the risk ...... in patients with osteoporosis.

@en

prefLabel

Eldecalcitol reduces the risk ...... in patients with osteoporosis.

@ast

Eldecalcitol reduces the risk ...... in patients with osteoporosis.

@en

P1476

Eldecalcitol reduces the risk ...... in patients with osteoporosis.

@en

P2093

Hiroshi Hagino

http://www.w3.org/2001/XMLSchema#string

Masao Fukunaga

http://www.w3.org/2001/XMLSchema#string

Masataka Shiraki

http://www.w3.org/2001/XMLSchema#string

Toshio Matsumoto

http://www.w3.org/2001/XMLSchema#string

Toshitaka Nakamura

http://www.w3.org/2001/XMLSchema#string

Toshiyuki Takano

http://www.w3.org/2001/XMLSchema#string

P2860

Alendronate improves QOL of postmenopausal women with osteoporosis.

A new active vitamin D3 analog, eldecalcitol, prevents the risk of osteoporotic fractures--a randomized, active comparator, double-blind study.

Meta-analyses of therapies for postmenopausal osteoporosis. VIII: Meta-analysis of the efficacy of vitamin D treatment in preventing osteoporosis in postmenopausal women.

Systematic review of the benefits and harms of calcitriol and alfacalcidol for fractures and falls.

Association of prevalent vertebral fractures, bone density, and alendronate treatment with incident vertebral fractures: effect of number and spinal location of fractures. The Fracture Intervention Trial Research Group.

The relationship of health-related quality of life to prevalent and incident vertebral fractures in postmenopausal women with osteoporosis: results from the Multiple Outcomes of Raloxifene Evaluation Study.

Effect of eldecalcitol, an active vitamin D analog, on hip structure and biomechanical properties: 3D assessment by clinical CT.

Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: results from the MORE trial.

A comparison of incidences of vertebral fracture in Japanese patients with involutional osteoporosis treated with risedronate and etidronate: a randomized, double-masked trial.

P2888

s00774-012-0397-6

P304

183-189

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00774-012-0397-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-11-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232917920

http://www.w3.org/2001/XMLSchema#string

P698

23129180

http://www.w3.org/2001/XMLSchema#string

P921

quality of life

P932

3590407

http://www.w3.org/2001/XMLSchema#string